Radioimmunotherapy for mantle cell lymphoma: 5-year follow-up of 90 patients from the international RIT registry

To assess the efficacy of radioimmunotherapy (RIT) with (90)yttrium-ibrutinib-tiuxetan (90Y-IT) in mantle cell lymphoma, data from 90 patients registered in the RIT Network with a median follow-up (FU) of 5.5 years after RIT were evaluated. 90Y-IT was given as first-line therapy in 45 (50%) and for...

Descripción completa

Detalles Bibliográficos
Autores principales: Hohloch, Karin, Windemuth-Kieselbach, Christine, Zinzani, Pier Luigi, Cacchione, Roberto, Jurczak, Wojciech, Suh, C., Trümper, Lorenz, Scholz, Christian W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196943/
https://www.ncbi.nlm.nih.gov/pubmed/32125469
http://dx.doi.org/10.1007/s00277-020-03956-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196943/
https://www.ncbi.nlm.nih.gov/pubmed/32125469
http://dx.doi.org/10.1007/s00277-020-03956-0

Ejemplares similares